Annette Tumolo's most recent trade in Telesis Bio Inc was a trade of 70,129 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 6, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Telesis Bio Inc
|
Annette Tumolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2023 | 70,129 | 70,129 | - | - | Stock Option (right to buy) | |
Telesis Bio Inc
|
Annette Tumolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2023 | 46,752 | 121,363 | - | 0 | Common Stock | |
Telesis Bio Inc
|
Annette Tumolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2023 | 36,406 | 157,769 | - | 0 | Common Stock | |
Telesis Bio Inc
|
Annette Tumolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2023 | 30,362 | 30,362 | - | - | Stock Option (right to buy) | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Sale of securities on an exchange or to another person at price $ 750.05 per share. | 11 Nov 2021 | 4,800 | 4,593 (0%) | 0% | 750.1 | 3,600,240 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 2,400 | 600 | - | - | Non-Qualified Stock Option (right to buy) | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 215.98 per share. | 11 Nov 2021 | 2,400 | 7,593 (0%) | 0% | 216.0 | 518,352 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 1,800 | 1,200 | - | - | Non-Qualified Stock Option (right to buy) | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 326.15 per share. | 11 Nov 2021 | 1,800 | 9,393 (0%) | 0% | 326.2 | 587,070 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 1,113 | 1,671 | - | - | Non-Qualified Stock Option (right to buy) | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Sale of securities on an exchange or to another person at price $ 748.84 per share. | 11 Nov 2021 | 613 | 5,093 (0%) | 0% | 748.8 | 459,039 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 333.34 per share. | 11 Nov 2021 | 613 | 5,206 (0%) | 0% | 333.3 | 204,337 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 600 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.32 per share. | 11 Nov 2021 | 600 | 5,193 (0%) | 0% | 159.3 | 95,592 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 333.34 per share. | 11 Nov 2021 | 500 | 5,706 (0%) | 0% | 333.3 | 166,670 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Sale of securities on an exchange or to another person at price $ 750.00 per share. | 11 Nov 2021 | 500 | 4,593 (0%) | 0% | 750 | 375,000 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 524.30 per share. | 11 Nov 2021 | 433 | 6,139 (0%) | 0% | 524.3 | 227,022 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Sale of securities on an exchange or to another person at price $ 748.08 per share. | 11 Nov 2021 | 433 | 5,706 (0%) | 0% | 748.1 | 323,919 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 433 | 1,300 | - | - | Non-Qualified Stock Option (right to buy) | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 600 | 0 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 600 | 4,891 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 806.32 per share. | 07 Sep 2021 | 298 | 4,593 (0%) | 0% | 806.3 | 240,283 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 600 | 4,287 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 600 | 4,589 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 600 | 1,200 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 600 | 600 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 557 | 3,939 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 557 | 1,671 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.70 per share. | 03 Sep 2021 | 298 | 3,989 (0%) | 0% | 819.7 | 244,271 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.70 per share. | 03 Sep 2021 | 298 | 4,291 (0%) | 0% | 819.7 | 244,271 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.70 per share. | 03 Sep 2021 | 252 | 3,687 (0%) | 0% | 819.7 | 206,564 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 433 | 1,300 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 433 | 3,532 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 825.77 per share. | 02 Sep 2021 | 150 | 3,382 (0%) | 0% | 825.8 | 123,866 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Sale of securities on an exchange or to another person at price $ 792.58 per share. | 26 Aug 2021 | 600 | 3,099 (0%) | 0% | 792.6 | 475,548 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.32 per share. | 06 Nov 2020 | 1,200 | 5,322 (0%) | 0% | 159.3 | 191,184 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2020 | 1,200 | 600 | - | - | Non-Qualified Stock Option (right to buy) | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Sale of securities on an exchange or to another person at price $ 640.78 per share. | 06 Nov 2020 | 734 | 4,368 (0%) | 0% | 640.8 | 470,333 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Nov 2020 | 423 | 3,699 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Sale of securities on an exchange or to another person at price $ 641.53 per share. | 06 Nov 2020 | 246 | 4,122 (0%) | 0% | 641.5 | 157,816 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Sale of securities on an exchange or to another person at price $ 639.62 per share. | 06 Nov 2020 | 220 | 5,102 (0%) | 0% | 639.6 | 140,716 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2020 | 600 | 4,420 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2020 | 600 | 0 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 505.02 per share. | 11 Sep 2020 | 298 | 4,122 (0%) | 0% | 505.0 | 150,496 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 600 | 3,765 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 600 | 1,800 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 600 | 3,373 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 600 | 4,118 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 600 | 600 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 600 | 1,200 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.23 per share. | 04 Sep 2020 | 298 | 3,820 (0%) | 0% | 484.2 | 144,301 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.23 per share. | 04 Sep 2020 | 247 | 3,518 (0%) | 0% | 484.2 | 119,605 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.23 per share. | 04 Sep 2020 | 208 | 3,165 (0%) | 0% | 484.2 | 100,720 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2020 | 556 | 2,966 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2020 | 556 | 2,228 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 494.24 per share. | 03 Sep 2020 | 193 | 2,773 (0%) | 0% | 494.2 | 95,388 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2020 | 1,733 | 1,733 | - | - | Non-Qualified Stock Option (right to buy) | |
Bio-Rad Laboratories Inc. ...
|
Annette Tumolo | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2020 | 1,733 | 1,733 | - | - | Restricted Stock Units |